Delivery Order SPE2DB20D1109-SPE2DB25FP42E
- Not listed
- The Defense Logistics Agency awarded a $46,934.16 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin on July 18, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 units of Xeomin, a botulinum toxin used for medical treatments. To be performed in Conshohocken, Pennsylvania from August 9-30, 2023, this order is funded through DLA's portfolio of contracts for pharmaceuticals and medical supplies supporting the Department of Defense. As a top 10 federal contractor, Amerisourcebergen will deliver the products from its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for XEOMIN 100 Unit vials with a ceiling value of $8,381.10. This firm fixed price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Xeomin 100 unit vials. The $11,795.40 contract has a performance period through March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and does not have any major subcontractors identified. This delivery order is issued under an indefinite delivery contract...
- The Defense Logistics Agency Troop Support Medical awarded a $2,621.20 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 units of Xeomin, a botulinum toxin type A. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from September 1, 2023 through September 22, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor, and no...
- The Defense Logistics Agency Troop Support Medical awarded a $31,454 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The place of performance is Conshohocken, Pennsylvania. The period of performance is from September 26, 2023 through October 18, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will deliver botulinum toxin type A to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside...
- The Defense Logistics Agency Troop Support Medical awarded a $44,036 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin, a botulinum toxin type A. The contract has a period of performance from August 22, 2023 through September 13, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring a wide...
- The Defense Logistics Agency (DLA) awarded a $1,425 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 50-unit vials of the drug Xeomin. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also holds a...
- The Defense Logistics Agency awarded a $31,454 delivery order to Amerisourcebergen Drug Corporation for 200 vials of Xeomin. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support Defense Logistics Agency requirements. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract vehicle to procure this botulinum toxin medication for the agency's medical supply needs....
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $115,332.80 firm fixed-price delivery order contract to provide 4562199421 units of Xeomin 200 unit vials. The contract has a period of performance from September 15, 2023 through October 6, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. As the prime contractor, Amerisourcebergen Drug Corporation will leverage its parent company Amerisourcebergen...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP42EDelivery Order
The Defense Logistics Agency awarded a $11,174.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Xeomin 200 Unit Vials, with completion scheduled for August 8, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's comprehensive IDC vehicle enables supply of a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems globally. This delivery order for Xeomin, a botulinum toxin therapeutic commonly used in military medical settings, exemplifies the company's role in fulfilling specialized pharmaceutical requirements through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 7/18/25 |